Log In

Correction to: A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma

Files

VeldhuijzenVanZanten2018_Article_CorrectionToAPhaseIIIS... (526.32 KB)

Publication date

2018-01-01

Authors

Veldhuijzen van Zanten, Sophie E.M.
El‑Khouly, Fatma E.
Jansen, Marc
Bakker, Dewi P.
Sanchez Aliaga, Esther
Haasbeek, Cornelis J.A.
Wolf, Nicole I.
Zwaan, C. Michel
Vandertop, W. Peter
van Vuurden, Dannis G.

Editors

Advisors

Supervisors

DOI

https://doi.org/10.1007/s11060-017-2636-0

Document Type

Comment

Metadata

Show full item record

Collections

UMC Repository
Open Access logo

License

taverne

Abstract

Correction to: J Neurooncol DOI 10.1007/s11060-017-2575-9

Keywords

Taverne, Clinical Neurology, Neurology, Oncology, Cancer Research, Published Erratum

Citation

Veldhuijzen van Zanten, S E M, El‑Khouly, F E, Jansen, M H A, Bakker, D P, Sanchez Aliaga, E, Haasbeek, C J A, Wolf, N I, Zwaan, C M, Vandertop, W P, van Vuurden, D G & Kaspers, G J L 2018, 'Correction to : A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma', Journal of Neuro-Oncology, vol. 136, no. 1, pp. 219-220. https://doi.org/10.1007/s11060-017-2636-0

URI

http://hdl.handle.net/1874/372981